- Salesforce announces high-profile cooperation with two AI giants
- Despite that - there is little to no gain in price
- Fundamentals look strong, but technical indicators - not so much
- Salesforce announces high-profile cooperation with two AI giants
- Despite that - there is little to no gain in price
- Fundamentals look strong, but technical indicators - not so much
Salesforce announced on October 14 two strategic extensions of collaboration – with OpenAI and Anthropic – aimed at deepening the integration of AI solutions within the Agentforce 360 ecosystem.
The collaboration with OpenAI involves connecting the Agentforce 360 platform with ChatGPT, enabling users to search sales data, analyze customer conversations, and create visualizations in Tableau using simple text queries. Additionally, the companies will offer tools for building AI agents and prompts using the latest OpenAI models, including GPT-5, as well as a new sales feature in ChatGPT for Salesforce customers, providing full control over data and customer relationships.
Simultaneously, Salesforce announced an extension of collaboration with Anthropic, focusing on delivering AI solutions for regulated and data-sensitive sectors. The Claude model will become the foundation for the Agentforce 360 platform, with initial implementations targeting the financial sector. Both companies also plan deeper integration of Claude with Slack, allowing users access to AI tools directly within team collaboration applications.
Salesforce has been performing very well in recent years, consistently increasing its scale of operations and revenues year over year. The company is executing a thoughtful development strategy in the area of artificial intelligence, which is already starting to yield tangible results in the form of increased productivity and improved margins. AI could become a kind of operational leverage for Salesforce, allowing it to scale both costs and profits.
Despite dynamic growth, the company's valuation remains relatively conservative by technology industry standards:
- P/E ratio is around 36
- Price to sales is 5
- Price to book value is 3
Despite this optimistic backdrop, Salesforce shares lost about 15% of their value in 2025. Moreover, even today's announcement of extended collaboration with OpenAI failed to reverse the negative trend. The company's stock continues to decline during the session, losing over 1% today. Not long ago, similar announcements of any collaboration with OpenAI could trigger double-digit increases in technology companies' valuations. Have investors stopped believing in the "magic" of artificial intelligence, or is Salesforce's fundamental situation weaker than a superficial analysis suggests? This is a question that will likely be answered in the upcoming quarterly results.
CRM.US (D1)
Source: xStation5
The technical situation on the chart looks dramatic for buyers. The company remains in a downward trend that has persisted for almost a year and has been repeatedly confirmed by price bouncing off the trend line with periodic supply gaps. Moreover, in April this year, we observed the so-called "Death Cross," which is the crossing of the EMA50 and EMA200 averages, followed quickly by the "Bearish Crossover," which is the crossing of EMA200 by EMA100 (from above). The price is inexorably approaching the support level at 229 more frequently, and soon it will intersect with the trend line. Buyers must hurry to reverse the trend if they want to prevent a correction to the level of 194 dollars — the minimum from 2 years ago.
⏬US100 is down 0.5% on Oracle news
Stock of the Month: Will Meta win the AI race?
Intel down 5% 📉
JPMorgan, Goldman Sachs, and Citigroup: Sector Overview and Challenges
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
